Fact CheckerSign in

NCT07890090Recruiting

THE EFFECT OF EDUCATION IN PATIENTS WITH HYPERTENSION

The Effect Of Dısease Management Educatıon Provıded To Indıvıduals Dıagnosed Wıth Hypertensıon On Theır Perceptıon Of Health And Level Of Burnout

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

Educational interventions play an extensive role in the literature on hypertension disease management. It has been reported that patient education practices increase individuals' level of knowledge, improve sleep and quality of life, ensure the control of hypertension, are effective in developing self-management skills, reduce body weight and body mass index, are effective in controlling harmful lifestyle habits, increase treatment adherence and healthy lifestyle behaviors, improve health literacy and self-efficacy levels, positively affect rational medication use, and strengthen adaptation to the disease. Accordingly, educational interventions for patients with hypertension play a fundamental role in improving treatment success and long-term health outcomes by supporting individuals' active participation in disease management. However, most studies conducted in the context of hypertension have focused on medication adherence, blood pressure control, or the physiological effects of lifestyle changes. In contrast, no study examining the effects of educational interventions for disease management on the health perception and burnout levels of individuals with hypertension has been found in the literature. The aim of this study is to determine the effects of disease management education provided to individuals diagnosed with hypertension on their health perception and burnout levels. The study aims to provide practical implications for both individual patient outcomes (psychosocial variables) and healthcare practices (the planning and implementation of patient education programs).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
76 (estimated)
First submitted
12 Oct 2026
Start date
1 Oct 2026
Primary completion date
1 Dec 2026
Lead sponsor
Inonu University
NCT number
NCT07890090

What you commit to

  • Study type: Interventional
  • Planned participants: 76
  • From 1 Oct 2026 to the primary completion date, 1 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • \*\*Inclusion Criteria\*\*
  • Individuals who agree to participate in the study.
  • Individuals aged 18 years or older.
  • Individuals diagnosed with hypertension for at least 6 months.
  • Individuals who are literate.
  • Individuals who have sufficient proficiency in Turkish to communicate effectively and speak Turkish.
  • Individuals whose physical and cognitive health status is adequate to complete the data collection forms planned for the study (i.e., individuals without psychiatric, hearing, or visual impairments).
  • Individuals who have not previously received structured education on hypertension management.
  • Outpatients and inpatients admitted to Batman Training and Research Hospital.
    • \*\*Exclusion Criteria\*\*
  • Individuals with significant intellectual, psychological, or cognitive impairments
  • Individuals with disabilities resulting from physical functional limitations

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Batman Training and Research Hospital
Coordinator of this site? Confirm its status
BatmanTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.